40-F Filing
Filing Information
| Form Type | 40-F |
| Accession Number | 0001193125-18-140678 |
| Period End Date | 20171231 |
| Filing Date | 20180430 |
| Fiscal Year | 2017 |
| Fiscal Period | FY |
| XBRL Instance | cron-20171231.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
64 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash |
CashAndCashEquivalents
|
9.21M | CAD | Point-in-time |
| Cash |
CashAndCashEquivalents
|
1.13M | CAD | Point-in-time |
| Cash |
CashAndCashEquivalents
|
3.46M | CAD | Point-in-time |
| Accounts receivable |
CurrentTradeReceivables
|
107,000.00 | CAD | Point-in-time |
| Accounts receivable |
CurrentTradeReceivables
|
1.14M | CAD | Point-in-time |
| Sales tax receivable |
CurrentReceivablesFromTaxesOtherThanIncomeTax
|
3.11M | CAD | Point-in-time |
| Prepaids and other receivables |
CurrentPrepaymentsAndOtherCurrentAssets
|
503,000.00 | CAD | Point-in-time |
| Prepaids and other receivables |
CurrentPrepaymentsAndOtherCurrentAssets
|
790,000.00 | CAD | Point-in-time |
| Biological assets |
CurrentBiologicalAssets
|
1.79M | CAD | Point-in-time |
| Biological assets |
CurrentBiologicalAssets
|
3.72M | CAD | Point-in-time |
| Inventory |
Inventories
|
1.91M | CAD | Point-in-time |
| Inventory |
Inventories
|
8.42M | CAD | Point-in-time |
| Loans receivable |
CurrentLoansAndReceivables
|
309,000.00 | CAD | Point-in-time |
| Loans receivable |
CurrentLoansAndReceivables
|
314,000.00 | CAD | Point-in-time |
| Current assets |
CurrentAssets
|
26.70M | CAD | Point-in-time |
| Current assets |
CurrentAssets
|
8.09M | CAD | Point-in-time |
| Investment in Whistler |
InvestmentAccountedForUsingEquityMethod
|
3.81M | CAD | Point-in-time |
| Investment in Whistler |
InvestmentAccountedForUsingEquityMethod
|
2.57M | CAD | Point-in-time |
| Other investments |
NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
|
5.13M | CAD | Point-in-time |
| Other investments |
NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
|
1.35M | CAD | Point-in-time |
| Property, plant and equipment |
PropertyPlantAndEquipment
|
14.12M | CAD | Point-in-time |
| Property, plant and equipment |
PropertyPlantAndEquipment
|
56.17M | CAD | Point-in-time |
| Property, plant and equipment |
PropertyPlantAndEquipment
|
2.70M | CAD | Point-in-time |
| Intangible assets |
IntangibleAssetsOtherThanGoodwill
|
1.61M | CAD | Point-in-time |
| Intangible assets |
IntangibleAssetsOtherThanGoodwill
|
11.21M | CAD | Point-in-time |
| Intangible assets |
IntangibleAssetsOtherThanGoodwill
|
11.21M | CAD | Point-in-time |
| Goodwill |
Goodwill
|
392,000.00 | CAD | Point-in-time |
| Goodwill |
Goodwill
|
1.79M | CAD | Point-in-time |
| Goodwill |
Goodwill
|
1.79M | CAD | Point-in-time |
| Assets |
Assets
|
101.03M | CAD | Point-in-time |
| Assets |
Assets
|
42.90M | CAD | Point-in-time |
| Accounts payable and other liabilities |
TradeAndOtherCurrentPayables
|
7.88M | CAD | Point-in-time |
| Accounts payable and other liabilities |
TradeAndOtherCurrentPayables
|
1.18M | CAD | Point-in-time |
| Purchase price liability |
CurrentPayablesForPurchaseOfNoncurrentAssets
|
2.59M | CAD | Point-in-time |
| Mortgage payable |
CurrentSecuredBankLoansReceivedAndCurrentPortionOfNoncurrentSecuredBankLoansReceived
|
4.00M | CAD | Point-in-time |
| Current liabilities |
CurrentLiabilities
|
7.88M | CAD | Point-in-time |
| Current liabilities |
CurrentLiabilities
|
7.77M | CAD | Point-in-time |
| Construction loan payable |
NoncurrentPortionOfNoncurrentLoansReceived
|
5.37M | CAD | Point-in-time |
| Deferred income tax liability |
DeferredTaxLiabilities
|
1.42M | CAD | Point-in-time |
| Deferred income tax liability |
DeferredTaxLiabilities
|
1.46M | CAD | Point-in-time |
| Liabilities |
Liabilities
|
14.66M | CAD | Point-in-time |
| Liabilities |
Liabilities
|
9.22M | CAD | Point-in-time |
| Share capital |
IssuedCapital
|
33.59M | CAD | Point-in-time |
| Share capital |
IssuedCapital
|
83.56M | CAD | Point-in-time |
| Warrants |
Warrants
|
3.98M | CAD | Point-in-time |
| Warrants |
Warrants
|
3.36M | CAD | Point-in-time |
| Share-based reserve |
ReserveOfSharebasedPayments
|
599,000.00 | CAD | Point-in-time |
| Share-based reserve |
ReserveOfSharebasedPayments
|
735,000.00 | CAD | Point-in-time |
| Share-based reserve |
ReserveOfSharebasedPayments
|
2.29M | CAD | Point-in-time |
| Accumulated deficit |
RetainedEarnings
|
-6.21M | CAD | Point-in-time |
| Accumulated deficit |
RetainedEarnings
|
-3.72M | CAD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncome
|
880,000.00 | CAD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncome
|
1.58M | CAD | Point-in-time |
| Equity |
Equity
|
33.68M | CAD | Point-in-time |
| Equity |
Equity
|
86.37M | CAD | Point-in-time |
| Equity |
Equity
|
11.70M | CAD | Point-in-time |
| Equity and liabilities |
EquityAndLiabilities
|
42.90M | CAD | Point-in-time |
| Equity and liabilities |
EquityAndLiabilities
|
101.03M | CAD | Point-in-time |
| Going concern |
GoingConcern
|
- | CAD | Point-in-time |
| Going concern |
GoingConcern
|
- | CAD | Point-in-time |
| Commitments and contingencies |
Contingencies
|
- | CAD | Point-in-time |
| Commitments and contingencies |
Contingencies
|
- | CAD | Point-in-time |
| Subsequent events |
SubsequentEvents
|
- | CAD | Point-in-time |
| Subsequent events |
SubsequentEvents
|
- | CAD | Point-in-time |
Income Statement
51 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Product sales |
Revenue
|
554,000.00 | CAD | Annual |
| Product sales |
Revenue
|
4.08M | CAD | Annual |
| Inventory expensed to cost of sales |
CostOfMerchandiseSold
|
384,000.00 | CAD | Annual |
| Inventory expensed to cost of sales |
CostOfMerchandiseSold
|
4.49M | CAD | Annual |
| Production costs |
ProductionCost
|
356,000.00 | CAD | Annual |
| Production costs |
ProductionCost
|
3.98M | CAD | Annual |
| Unrealized gain on revaluation of biological assets |
GainsLossesOnFairValueAdjustmentBiologicalAssets
|
2.18M | CAD | Annual |
| Unrealized gain on revaluation of biological assets |
GainsLossesOnFairValueAdjustmentBiologicalAssets
|
11.62M | CAD | Annual |
| Total recovery of cost of sales |
CostOfSalesAndRecovery
|
-1.44M | CAD | Annual |
| Total recovery of cost of sales |
CostOfSalesAndRecovery
|
-3.15M | CAD | Annual |
| Gross profit |
GrossProfit
|
7.23M | CAD | Annual |
| Gross profit |
GrossProfit
|
1.99M | CAD | Annual |
| General and administration |
GeneralAndAdministrativeExpense
|
6.93M | CAD | Annual |
| General and administration |
GeneralAndAdministrativeExpense
|
3.44M | CAD | Annual |
| Stock-based payments |
ExpenseFromShareBasedPaymentTransactionsWithEmployeesAndNonemployees
|
307,000.00 | CAD | Annual |
| Stock-based payments |
ExpenseFromShareBasedPaymentTransactionsWithEmployeesAndNonemployees
|
1.86M | CAD | Annual |
| Depreciation |
DepreciationExpense
|
382,000.00 | CAD | Annual |
| Depreciation |
DepreciationExpense
|
541,000.00 | CAD | Annual |
| Total operating expenses |
OperatingExpenseExcludingCostOfSales
|
9.34M | CAD | Annual |
| Total operating expenses |
OperatingExpenseExcludingCostOfSales
|
4.12M | CAD | Annual |
| Operating loss |
ProfitLossFromOperatingActivities
|
-2.13M | CAD | Annual |
| Operating loss |
ProfitLossFromOperatingActivities
|
-2.11M | CAD | Annual |
| Interest expense |
InterestExpense
|
126,000.00 | CAD | Annual |
| Interest expense |
InterestExpense
|
232,000.00 | CAD | Annual |
| Share of income from Whistler investment |
ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
|
163,000.00 | CAD | Annual |
| Share of income from Whistler investment |
ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
|
165,000.00 | CAD | Annual |
| Gain (loss) on other investments |
GainsLossesOnDisposalsOfInvestments
|
-310,000.00 | CAD | Annual |
| Gain (loss) on other investments |
GainsLossesOnDisposalsOfInvestments
|
4.86M | CAD | Annual |
| Reversal of impairment loss on loan receivable |
ReversalOfImpairmentLossRecognisedInProfitOrLossLoansAndAdvances
|
725,000.00 | CAD | Annual |
| Other income |
MiscellaneousOtherOperatingIncome
|
27,000.00 | CAD | Annual |
| Total other income |
OtherIncome
|
373,000.00 | CAD | Annual |
| Total other income |
OtherIncome
|
4.90M | CAD | Annual |
| Income (loss) before income taxes |
ProfitLossBeforeTax
|
-1.76M | CAD | Annual |
| Income (loss) before income taxes |
ProfitLossBeforeTax
|
2.79M | CAD | Annual |
| Income tax expense (recovery) |
IncomeTaxExpenseContinuingOperations
|
-568,000.00 | CAD | Annual |
| Income tax expense (recovery) |
IncomeTaxExpenseContinuingOperations
|
298,000.00 | CAD | Annual |
| Net income (loss) |
ProfitLoss
|
2.49M | CAD | Annual |
| Net income (loss) |
ProfitLoss
|
-1.19M | CAD | Annual |
| Gain on revaluation of other investments, net of tax |
OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation
|
1.58M | CAD | Annual |
| Gain on revaluation of other investments, net of tax |
OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation
|
947,000.00 | CAD | Annual |
| Unrealized gains reclassified to net income |
OtherComprehensiveIncomeUnrealizedGainsReclassifiedToProfitOrLossNetOfTax
|
-1.65M | CAD | Annual |
| Comprehensive income |
ComprehensiveIncome
|
1.79M | CAD | Annual |
| Comprehensive income |
ComprehensiveIncome
|
394,000.00 | CAD | Annual |
| Basic |
BasicEarningsLossPerShare
|
-0.02 | CAD | Annual |
| Basic |
BasicEarningsLossPerShare
|
0.02 | CAD | Annual |
| Diluted |
DilutedEarningsLossPerShare
|
-0.02 | CAD | Annual |
| Diluted |
DilutedEarningsLossPerShare
|
0.01 | CAD | Annual |
| Basic |
WeightedAverageShares
|
134.80M | shares | Annual |
| Basic |
WeightedAverageShares
|
78.25M | shares | Annual |
| Diluted |
AdjustedWeightedAverageShares
|
78.25M | shares | Annual |
| Diluted |
AdjustedWeightedAverageShares
|
176.79M | shares | Annual |
Cash Flow Statement
74 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income (loss) |
ProfitLoss
|
2.49M | CAD | Annual |
| Net income (loss) |
ProfitLoss
|
-1.19M | CAD | Annual |
| Stock-based payments |
AdjustmentsForSharebasedPayments
|
307,000.00 | CAD | Annual |
| Stock-based payments |
AdjustmentsForSharebasedPayments
|
1.86M | CAD | Annual |
| Depreciation |
AdjustmentsForDepreciationExpense
|
382,000.00 | CAD | Annual |
| Depreciation |
AdjustmentsForDepreciationExpense
|
996,000.00 | CAD | Annual |
| Share of income from investment in Whistler |
ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
|
163,000.00 | CAD | Annual |
| Share of income from investment in Whistler |
ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
|
165,000.00 | CAD | Annual |
| Loss (gain) on other investments |
OtherAdjustmentsForNoncashItems
|
-4.86M | CAD | Annual |
| Loss (gain) on other investments |
OtherAdjustmentsForNoncashItems
|
310,000.00 | CAD | Annual |
| Reversal of impairment loss on loan receivable |
AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossLoansAndAdvances
|
-725,000.00 | CAD | Annual |
| Deferred income tax expense (recovery) |
AdjustmentsForDeferredTaxExpense
|
298,000.00 | CAD | Annual |
| Deferred income tax expense (recovery) |
AdjustmentsForDeferredTaxExpense
|
-568,000.00 | CAD | Annual |
| Cash flows from used in operations before changes in working capital |
CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
|
624,000.00 | CAD | Annual |
| Cash flows from used in operations before changes in working capital |
CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
|
-1.65M | CAD | Annual |
| Increase in accounts receivable |
AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
|
-1.03M | CAD | Annual |
| Increase in accounts receivable |
AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
|
-57,000.00 | CAD | Annual |
| Increase in sales tax receivable |
AdjustmentsForDecreaseIncreaseInSalesTaxReceivable
|
-3.11M | CAD | Annual |
| Increase in prepaids and other receivables |
AdjustmentsForIncreaseDecreaseInPrepaymentsAndOtherReceivables
|
-376,000.00 | CAD | Annual |
| Increase in prepaids and other receivables |
AdjustmentsForIncreaseDecreaseInPrepaymentsAndOtherReceivables
|
-287,000.00 | CAD | Annual |
| Increase in biological assets |
AdjustmentsForDecreaseIncreaseInBiologicalAssets
|
-714,000.00 | CAD | Annual |
| Increase in biological assets |
AdjustmentsForDecreaseIncreaseInBiologicalAssets
|
-1.93M | CAD | Annual |
| Increase in inventory |
AdjustmentsForDecreaseIncreaseInInventories
|
-6.51M | CAD | Annual |
| Increase in inventory |
AdjustmentsForDecreaseIncreaseInInventories
|
-929,000.00 | CAD | Annual |
| Increase in accrued interest on loan receivable |
AdjustmentsForDecreaseIncreaseInAccruedInterestReceivable
|
-5,000.00 | CAD | Annual |
| Increase in accrued interest on loan receivable |
AdjustmentsForDecreaseIncreaseInAccruedInterestReceivable
|
-7,000.00 | CAD | Annual |
| Increase (decrease) in accounts payable and other liabilities |
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
|
6.70M | CAD | Annual |
| Increase (decrease) in accounts payable and other liabilities |
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables
|
-2.75M | CAD | Annual |
| Cash flows used in operating activities |
CashFlowsFromUsedInOperatingActivities
|
-5.55M | CAD | Annual |
| Cash flows used in operating activities |
CashFlowsFromUsedInOperatingActivities
|
-6.48M | CAD | Annual |
| Cash acquired from Peace Naturals |
CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
|
109,000.00 | CAD | Annual |
| Advances of loans receivable to Peace Naturals prior to acquisition |
CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities
|
771,000.00 | CAD | Annual |
| Receipts of loans receivable |
CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities
|
423,000.00 | CAD | Annual |
| Acquisition of Peace Naturals |
CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
|
6.25M | CAD | Annual |
| Repayment of purchase price liability |
PaymentOfContingentConsiderationLiabilities
|
2.59M | CAD | Annual |
| Investment in Whistler |
AggregateCashFlowsUsedToInvestInOtherSignificantlyInfluencedEntitiesClassifiedAsInvestingActivities
|
1.08M | CAD | Annual |
| Dividends received from Whistler investment |
DividendsReceivedFromAssociatesClassifiedAsInvestingActivities
|
2,000.00 | CAD | Annual |
| Proceeds from sale of other investments |
ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
|
10.88M | CAD | Annual |
| Acquisition of additional shares in AbCann |
PurchaseOfAvailableforsaleFinancialAssets
|
1.02M | CAD | Annual |
| Payment to exercise AbCann warrants |
CashOutflowFromTheExerciseOfWarrants
|
2.27M | CAD | Annual |
| Purchase of property, plant and equipment |
PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
|
1.52M | CAD | Annual |
| Purchase of property, plant and equipment |
PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
|
42.70M | CAD | Annual |
| Cash flows used in investing activities |
CashFlowsFromUsedInInvestingActivities
|
-38.77M | CAD | Annual |
| Cash flows used in investing activities |
CashFlowsFromUsedInInvestingActivities
|
-8.01M | CAD | Annual |
| Repayment of deposit payable |
RepaymentOfDepositPayable
|
200,000.00 | CAD | Annual |
| Repayment of promissory note payable |
RepaymentsOfBondsNotesAndDebentures
|
950,000.00 | CAD | Annual |
| Repayment of loans |
RepaymentsOfBorrowingsClassifiedAsFinancingActivities
|
2.69M | CAD | Annual |
| Repayment of mortgage payable |
RepaymentsOfCurrentBorrowings
|
500,000.00 | CAD | Annual |
| Repayment of mortgage payable |
RepaymentsOfCurrentBorrowings
|
4.00M | CAD | Annual |
| Proceeds from construction loan payable |
ProceedsFromNoncurrentBorrowings
|
6.30M | CAD | Annual |
| Transaction costs paid on construction loan payable |
PaymentsForDebtIssueCosts
|
1.28M | CAD | Annual |
| Proceeds from exercise of warrants |
ProceedsFromExerciseOfWarrants
|
418,000.00 | CAD | Annual |
| Proceeds from exercise of warrants |
ProceedsFromExerciseOfWarrants
|
1.62M | CAD | Annual |
| Proceeds from issuance of warrants |
CashInflowFromIssuingWarrants
|
2.83M | CAD | Annual |
| Proceeds from exercise of options |
ProceedsFromExerciseOfOptions
|
591,000.00 | CAD | Annual |
| Proceeds from exercise of options |
ProceedsFromExerciseOfOptions
|
104,000.00 | CAD | Annual |
| Proceeds from issuance of shares |
ProceedsFromIssuingShares
|
17.97M | CAD | Annual |
| Proceeds from issuance of shares |
ProceedsFromIssuingShares
|
49.59M | CAD | Annual |
| Share issuance costs |
PaymentsForShareIssueCosts
|
162,000.00 | CAD | Annual |
| Share issuance costs |
PaymentsForShareIssueCosts
|
2.77M | CAD | Annual |
| Cash flows provided by financing activities |
CashFlowsFromUsedInFinancingActivities
|
16.82M | CAD | Annual |
| Cash flows provided by financing activities |
CashFlowsFromUsedInFinancingActivities
|
50.06M | CAD | Annual |
| Net change in cash |
IncreaseDecreaseInCashAndCashEquivalents
|
5.74M | CAD | Annual |
| Net change in cash |
IncreaseDecreaseInCashAndCashEquivalents
|
2.34M | CAD | Annual |
| Cash - beginning of year |
CashAndCashEquivalents
|
9.21M | CAD | Point-in-time |
| Cash - beginning of year |
CashAndCashEquivalents
|
1.13M | CAD | Point-in-time |
| Cash - beginning of year |
CashAndCashEquivalents
|
3.46M | CAD | Point-in-time |
| Cash - end of year |
CashAndCashEquivalents
|
9.21M | CAD | Point-in-time |
| Cash - end of year |
CashAndCashEquivalents
|
1.13M | CAD | Point-in-time |
| Cash - end of year |
CashAndCashEquivalents
|
3.46M | CAD | Point-in-time |
| Interest received |
InterestReceived
|
22,000.00 | CAD | Annual |
| Interest received |
InterestReceived
|
48,000.00 | CAD | Annual |
| Interest paid |
InterestPaid1
|
294,000.00 | CAD | Annual |
| Interest paid |
InterestPaid1
|
200,000.00 | CAD | Annual |
Stockholders Equity
22 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
Equity
|
33.68M | CAD | Point-in-time |
| Balance |
Equity
|
86.37M | CAD | Point-in-time |
| Balance |
Equity
|
11.70M | CAD | Point-in-time |
| Shares issued |
IssueOfEquity
|
20.93M | CAD | Annual |
| Shares issued |
IssueOfEquity
|
49.59M | CAD | Annual |
| Share issuance costs |
ShareIssueRelatedCost
|
2.77M | CAD | Annual |
| Share issuance costs |
ShareIssueRelatedCost
|
162,000.00 | CAD | Annual |
| Vesting of options |
IncreaseDecreaseThroughSharebasedPaymentTransactions
|
178,000.00 | CAD | Annual |
| Vesting of options |
IncreaseDecreaseThroughSharebasedPaymentTransactions
|
1.86M | CAD | Annual |
| Options exercised |
IncreaseDecreaseThroughExerciseOfOptions
|
591,000.00 | CAD | Annual |
| Options exercised |
IncreaseDecreaseThroughExerciseOfOptions
|
103,000.00 | CAD | Annual |
| Warrants exercised |
IncreaseDecreaseThroughExerciseOfWarrantsEquity
|
418,000.00 | CAD | Annual |
| Warrants exercised |
IncreaseDecreaseThroughExerciseOfWarrantsEquity
|
1.62M | CAD | Annual |
| Conversion of convertible loans payable |
IncreaseDecreaseThroughConversionOfConvertibleInstruments
|
115,000.00 | CAD | Annual |
| Unrealized gains reclassified to net income |
IncreaseDecreaseThroughTransferBetweenRevaluationReserveAndRetainedEarnings
|
-1.65M | CAD | Annual |
| Net income |
ProfitLoss
|
2.49M | CAD | Annual |
| Net income |
ProfitLoss
|
-1.19M | CAD | Annual |
| Other comprehensive income |
OtherComprehensiveIncome
|
947,000.00 | CAD | Annual |
| Other comprehensive income |
OtherComprehensiveIncome
|
1.58M | CAD | Annual |
| Balance |
Equity
|
33.68M | CAD | Point-in-time |
| Balance |
Equity
|
86.37M | CAD | Point-in-time |
| Balance |
Equity
|
11.70M | CAD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.